Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer

Gut

Volumn 66, Issue 1, 2017, Pages 70-78

  Yu, Jun ^a   Feng, Qiang ^b,c   Wong, Sunny Hei ^a   Zhang, Dongya ^b   Yi Liang, Qiao ^a   Qin, Youwen ^b   Tang, Longqing ^b   Zhao, Hui ^b   Stenvang, Jan ^d   Li, Yanli ^b   Wang, Xiaokai ^b   Xu, Xiaoqiang ^b   Chen, Ning ^b   Wu, William Ka Kei ^a   Al Aama, Jumana ^b,e   Nielsen, Hans Jorgen ^f   Kiilerich, Pia ^c   Jensen, Benjamin Anderschou Holbech ^c   Yau, Tung On ^a   Lan, Zhou ^b   Jia, Huijue ^b   Li, Junhua ^b   Xiao, Liang ^b   Lam, Thomas Yuen Tung ^a   Ng, Siew Chien ^a   Cheng, Alfred Sze Lok ^a   Wong, Vincent Wai Sun ^a   Chan, Francis Ka Leung ^a   Xu, Xun ^b   Yang, Huanming ^b   Madsen, Lise ^b,c,g   Datz, Christian ^h   Tilg, Herbert ⁱ   Wang, Jian ^b   Brünner, Nils ^b,d   Kristiansen, Karsten ^b,c   Arumugam, Manimozhiyan ^b,j   Sung, Joseph Jao Yiu ^a   Wang, Jun ^b,c,e,k   more..

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b BGI SHENZHEN   (China)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^f HVIDOVRE HOSPITAL   (Denmark)

^g INSTITUTE OF MARINE RESEARCH   (Norway)

^h UNIVERSITY OF SALZBURG   (Austria)

ⁱ INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^j Capital Region   (Denmark)

^k MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

AGED; AREA UNDER THE CURVE; ARTICLE; AUSTRIA; BACTERIAL GENE; CHINESE; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DENMARK; DYSBIOSIS; EARLY CANCER DIAGNOSIS; ERYSIPELOTRICHACEAE; FECES ANALYSIS; FECES MICROFLORA; FEMALE; FRANCE; FUSOBACTERIUM NUCLEATUM; GENETIC ASSOCIATION; GENOME-WIDE ASSOCIATION STUDY; HUMAN; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; MARKER GENE; METAGENOMICS; MICROBIAL GENE; MICROBIOME; NON INVASIVE MEASUREMENT; PARVIMONAS MICRA; PEPTOSTREPTOCOCCUS; PEPTOSTREPTOCOCCUS STOMATIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SOLOBACTERIUM MOOREI; CASE CONTROL STUDY; CHINA; COLORECTAL NEOPLASMS; COMPLICATION; FECES; FIRMICUTES; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; VALIDATION STUDY;

AGED; AREA UNDER CURVE; AUSTRIA; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; CHINA; COHORT STUDIES; COLORECTAL NEOPLASMS; DENMARK; DYSBIOSIS; FECES; FEMALE; FIRMICUTES; FRANCE; FUSOBACTERIUM NUCLEATUM; GASTROINTESTINAL MICROBIOME; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; METAGENOMICS; MIDDLE AGED; PEPTOSTREPTOCOCCUS; ROC CURVE;

EID: 84942693814     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2015-309800     Document Type: Article

References (45)

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide. IARC CancerBase. Lyon, France: International Agency for Research on Cancer, 2013.
2. Galvan A, Ioannidis JP, Dragani TA. Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer. Trends Genet 2010;26:132-41.
3. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343:78-85.
4. Foulkes WD. Inherited susceptibility to common cancers. N Engl J Med 2008;359:2143-53.
5. Dove WF, Clipson L, Gould KA, et al. Intestinal neoplasia in the ApcMin mouse: independence from the microbial and natural killer (beige locus) status. Cancer Res 1997;57:812-14.
6. Arthur JC, Perez-Chanona E, Muhlbauer M, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012;338:120-3.
7. Cuevas-Ramos G, Petit CR, Marcq I, et al. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci USA 2010;107:11537-42.
8. Grivennikov SI, Wang K, Mucida D, et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 2012;491:254-8.
9. Toprak NU, Yagci A, Gulluoglu BM, et al. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin Microbiol Infect 2006;12:782-6.
10. Uronis JM, Muhlbauer M, Herfarth HH, et al. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS ONE 2009;4:e6026.
11. Wu S, Rhee KJ, Albesiano E, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 2009;15:1016-22.
12. Boleij A, Schaeps RM, Tjalsma H. Association between Streptococcus bovis and colon cancer. J Clin Microbiol 2009;47:516.
13. Seder CW, Kramer M, Long G, et al. Clostridium septicum aortitis: Report of two cases and review of the literature. J Vasc Surg 2009;49:1304-9.
14. Scanlan PD, Shanahan F, Clune Y, et al. Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol 2008;10:789-98.
15. Sobhani I, Tap J, Roudot-Thoraval F, et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE 2011;6:e16393.
16. Chen W, Liu F, Ling Z, et al. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS ONE 2012;7:e39743.
17. Castellarin M, Warren RL, Freeman JD, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012;22:299-306.
18. Kostic AD, Gevers D, Pedamallu CS, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 2012;22:292-8.
19. Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment. Cell Host Microbe 2013;14:207-15.
20. Rubinstein MR, Wang X, Liu W, et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 2013;14:195-206.
21. Zackular JP, Rogers MA, Ruffin MTt, et al. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res (Phila) 2014;7:1112-21.
22. Zeller G, Tap J, Voigt AY, et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol 2014;10:766.
23. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17:1471-4.
24. Godon JJ, Zumstein E, Dabert P, et al. Molecular microbial diversity of an anaerobic digestor as determined by small-subunit rDNA sequence analysis. Appl Environ Microbiol 1997;63:2802-13.
25. Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012;490:55-60.
26. Sunagawa S, Mende DR, Zeller G, et al. Metagenomic species profiling using universal phylogenetic marker genes. Nat Methods 2013;10:1196-9.
27. Markowitz VM, Chen IM, Palaniappan K, et al. IMG: the Integrated Microbial Genomes database and comparative analysis system. Nucleic Acids Res 2012;40: D115-22.
28. Peng H, Long F, Ding C. Feature selection based on mutual information: criteria of max-dependency, max-relevance, and min-redundancy. IEEE Trans Pattern Anal Mach Intell 2005;27:1226-38.
29. Kabat GC, Kim MY, Strickler HD, et al. A longitudinal study of serum insulin and glucose levels in relation to colorectal cancer risk among postmenopausal women. Br J Cancer 2012;106:227-32.
30. van Duijnhoven FJ, Bueno-De-Mesquita HB, Calligaro M, et al. Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut 2011;60:1094-102.
31. Feng Q, Liang S, Jia H, et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun 2015;6:6528.
32. Kanehisa M, Goto S, Sato Y, et al. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 2012;40:D109-14.
33. Baracos VE, Mackenzie ML. Investigations of branched-chain amino acids and their metabolites in animal models of cancer. J Nutr 2006; 136:237S-42S.
34. Gonçalves EM, Salomão EM, Gomes-Marcondes MCC. Leucine modulates the effect of Walker factor, a proteolysis-inducing factor-like protein from Walker tumours, on gene expression and cellular activity in C2C12 myotubes. Cytokine 2013;64:343-50.
35. Pedersen RM, Holt HM, Justesen US. Solobacterium moorei bacteremia: identification, antimicrobial susceptibility, and clinical characteristics. J Clin Microbiol 2011;49:2766-8.
36. Sundqvist G. Taxonomy, ecology, and pathogenicity of the root canal flora. Oral Surg Oral Med Oral Pathol 1994;78:522-30.
37. Knights D, Costello EK, Knight R. Supervised classification of human microbiota. FEMS Microbiol Rev 2011;35:343-59.
38. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464:59-65.
39. Li J, Jia H, Cai X, et al. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol 2014;32:834-41.
40. Ahn J, Sinha R, Pei Z, et al. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst 2013;105:1907-11.
41. Ciccarelli FD, Doerks T, von Mering C, et al. Toward automatic reconstruction of a highly resolved tree of life. Science 2006;311:1283-7.
42. Holmes I, Harris K, Quince C. Dirichlet multinomial mixtures: generative models for microbial metagenomics. PLoS ONE 2012;7:e30126.
43. Ding T, Schloss PD. Dynamics and associations of microbial community types across the human body. Nature 2014;509:357-60.
44. Kremer BH, van Steenbergen TJ. Peptostreptococcus micros coaggregates with Fusobacterium nucleatum and non-encapsulated Porphyromonas gingivalis. FEMS Microbiol Lett 2000;182:57-62.
45. Yoshioka M, Grenier D, Mayrand D. Binding of Actinobacillus actinomycetemcomitans lipopolysaccharides to Peptostreptococcus micros stimulates tumor necrosis factor alpha production by macrophage-like cells. Oral Microbiol Immunol 2005;20:118-21.